Arco C. Verhoeven

3.9k citations

27 papers · 3.0k indexed · 1 hit paper · h-index 19

Co-authors: Maarten Boers Annelies Boonen Sjef van der Linden George A. Wells David T. Felson Jennifer J. Anderson H. M. Markusse André J. Peeters
Topics: Rheumatoid Arthritis Research and Therapies (21 papers)Systemic Lupus Erythematosus Research (10 papers)Lymphoma Diagnosis and Treatment (6 papers)
Cited by: Rheumatology Hematology Genetics
Journals: The Lancet Cochrane Database of Systematic Reviews Annals of the Rheumatic Diseases
Partner nations: Netherlands Australia Denmark

In The Last Decade

Arco C. Verhoeven

27 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1997 800 citations Maarten Boers, Arco C. Verhoeven et al. The Lancet profile →

Peers

Countries citing papers authored by Arco C. Verhoeven

Since Specialization

Citations

This map shows the geographic impact of Arco C. Verhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arco C. Verhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arco C. Verhoeven more than expected).

Fields of papers citing papers by Arco C. Verhoeven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arco C. Verhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arco C. Verhoeven. The network helps show where Arco C. Verhoeven may publish in the future.

Co-authorship network of co-authors of Arco C. Verhoeven

This figure shows the co-authorship network connecting the top 25 collaborators of Arco C. Verhoeven. A scholar is included among the top collaborators of Arco C. Verhoeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arco C. Verhoeven. Arco C. Verhoeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interventions to improve return to work in depressed people 2020 ·Cochrane Database of Systematic Reviews ·Karen Nieuwenhuijsen,Jos Verbeek,Angela Neumeyer‐Gromen,Arco C. Verhoeven,Ute Bültmann,(unknown)	135
2	Interventions to improve return to work in depressed people 2014 ·Cochrane Database of Systematic Reviews ·Karen Nieuwenhuijsen,(unknown),Jos Verbeek,Angela Neumeyer‐Gromen,Hiske L. Hees,Arco C. Verhoeven,Christina M. van der Feltz‐Cornelis,Ute Bültmann	255
3	Interventions to improve occupational health in depressed people 2008 ·Cochrane Database of Systematic Reviews ·Karen Nieuwenhuijsen,Ute Bültmann,Angela Neumeyer‐Gromen,Arco C. Verhoeven,Jos Verbeek,Christina M. van der Feltz‐Cornelis	101
4	Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. 2004 ·PubMed ·(unknown),Maurits W. van Tulder,Maarten Boers,Arco C. Verhoeven,Herman J. Adèr,(unknown),Annelies Boonen,(unknown)	29
5	Risicofactoren voor lage-rugklachten in het beroep 2003 ·Tijdschrift voor bedrijfs- en verzekeringsgeneeskunde ·Alex Burdorf,Harald S. Miedema,Arco C. Verhoeven	3
6	COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention 2002 ·Arthritis & Rheumatism ·Robert Landewé,Maarten Boers,Arco C. Verhoeven,René Westhovens,Mart A F J van de Laar,H. M. Markusse,J. Christiaan van Denderen,(unknown),André J. Peeters,Ben A. C. Dijkmans,Piet Jacobs,Annelies Boonen,Désirée van der Heijde,Sjef van der Linden	442
7	Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example 2002 ·Arthritis Care & Research ·Karin Bruynesteyn,Désirée van der Heijde,Maarten Boers,Arco C. Verhoeven,Annelies Boonen,Sjef van der Linden,(unknown)	9
8	Association of baseline levels of markers of bone and cartilage degradation with long‐term progression of joint damage in patients with early rheumatoid arthritis 2002 ·Arthritis & Rheumatism ·Patrick Garnero,Robert Landewé,Maarten Boers,Arco C. Verhoeven,Sjef van der Linden,Stephan Christgau,Désirée van der Heijde,Annelies Boonen,Piet Geusens	147
9	Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage 2002 ·Arthritis & Rheumatism ·Leroy R. Lard,Maarten Boers,Arco C. Verhoeven,Koen Vos,Henk Visser,J. M. W. Hazes,A. H. Zwinderman,G. M. T. Schreuder,FC Breedveld,René R. P. de Vries,S van der Linden,Eric Zanelli,T. Huizinga	57
10	Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis 2001 ·Arthritis & Rheumatism ·Maarten Boers,Piet J. Kostense,Arco C. Verhoeven,Sjef van der Linden,(unknown)	62
11	Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high‐dose prednisolone 2001 ·Lara D. Veeken ·Arco C. Verhoeven,Maarten Boers,J.M. te Koppele,W.H. van der Laan,H. M. Markusse,Piet Geusens,S. van der Linden	23
12	Robustness and generalizability of smallest detectable difference in radiological progression. 2001 ·PubMed ·(unknown),D. van der Heijde,Karl Johnson,Karin Bruynesteyn,(unknown),Annelies Boonen,Arco C. Verhoeven,Paul Emery,Maarten Boers	23
13	American College of Rheumatology criteria for improvement in rheumatoid arthritis should only be calculated from scores that decrease on improvement 2001 ·Arthritis & Rheumatism ·Maarten Boers,Arco C. Verhoeven,Sjef van der Linden	3
14	Reliability of spot samples for assessment of urinary excretion of pyridinoline in patients with rheumatoid arthritis. 2001 ·PubMed ·Arco C. Verhoeven,Maarten Boers,J.M. te Koppele,W.H. van der Laan,J Roos,S. Van Der Linden	1
15	Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration 2000 ·Arthritis & Rheumatism ·Jennifer J. Anderson,George A. Wells,Arco C. Verhoeven,David T. Felson	400
16	Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis 2000 ·Annals of the Rheumatic Diseases ·Arco C. Verhoeven,(unknown),(unknown)	60
17	Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. 2000 ·PubMed ·Arco C. Verhoeven,Maarten Boers,S. Lidén	71
18	Combination therapy in rheumatoid arthritis: updated systematic review 1998 ·Lara D. Veeken ·Arco C. Verhoeven,Maarten Boers,Peter Tugwell	69
19	Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoide Artritis 1998 ·British journal of rheumatology ·Arco C. Verhoeven	61
20	Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisbreakdown → 1997 ·The Lancet ·Maarten Boers,Arco C. Verhoeven,H. M. Markusse,M A van de Laar,René Westhovens,J. Christiaan van Denderen,D. van Zeben,Ben A. C. Dijkmans,André J. Peeters,Piet Jacobs,H. R. Van Den Brink,Hubert J. A. Schouten,Désirée van der Heijde,Annelies Boonen,Sjef van der Linden	800

About Arco C. Verhoeven

Arco C. Verhoeven is a scholar working on Rheumatology, Medical Laboratory Technology and Statistics and Probability, having authored 27 papers that have together received 3.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (10 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Rheumatology (2.2k citations), Hematology (837 citations) and Genetics (356 citations). Arco C. Verhoeven has collaborated with scholars based in Netherlands, Australia and Denmark. Frequent co-authors include Maarten Boers, Annelies Boonen, Sjef van der Linden, George A. Wells, David T. Felson, Jennifer J. Anderson, H. M. Markusse, André J. Peeters, Ben A. C. Dijkmans and J. Christiaan van Denderen. Their work appears in journals such as The Lancet, Cochrane Database of Systematic Reviews and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact